POLBF (Poolbeg Pharma) Net Margin %: 0.00% (As of Dec. 2025)


What is Poolbeg Pharma Net Margin %?

Poolbeg Pharma POLBF -20.36% Net Margin % is 0.00% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, Poolbeg Pharma ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Poolbeg Pharma's Net Income for the six months ended in Dec. 2025 was $-4.71 Mil. Poolbeg Pharma's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Poolbeg Pharma's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Poolbeg Pharma's Net Margin % or its related term are showing as below:


POLBF's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

Poolbeg Pharma  (OTCPK:POLBF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Poolbeg Pharma Net Margin % Related Terms

Poolbeg Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Poolbeg Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Net Margin % Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00 0.00 0.00

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

POLBF vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Poolbeg Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Net Margin % falls into.


Poolbeg Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Poolbeg Pharma's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.624/0
= %

Poolbeg Pharma's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-4.708/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Poolbeg Pharma (POLBF) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Poolbeg Pharma and its competitors. According to the industry distribution chart, Poolbeg Pharma ranks #999999 out of 947 companies in the Biotechnology industry.
Is Poolbeg Pharma's Net Margin % too high?
Poolbeg Pharma's current Net Margin % is 0.00%. Based on the distribution chart, Poolbeg Pharma ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Poolbeg Pharma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Poolbeg Pharma ranks #999999 out of 947 companies for Net Margin %. This places Poolbeg Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Poolbeg Pharma and its competitors. Poolbeg Pharma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poolbeg Pharma Business Description

Other Exchanges POLB:UK7JN:Germany
Address 20 St. Andrew Street, The Clubhouse Holborn, London, GBR, EC4A 3AG
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.